These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 35803910)

  • 1. High levels of NRF2 sensitize temozolomide-resistant glioblastoma cells to ferroptosis via ABCC1/MRP1 upregulation.
    de Souza I; Monteiro LKS; Guedes CB; Silva MM; Andrade-Tomaz M; Contieri B; Latancia MT; Mendes D; Porchia BFMM; Lazarini M; Gomes LR; Rocha CRR
    Cell Death Dis; 2022 Jul; 13(7):591. PubMed ID: 35803910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation.
    Su IC; Su YK; Setiawan SA; Yadav VK; Fong IH; Yeh CT; Lin CM; Liu HW
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of temozolomide on glioma cells is sensitized by RSL3-induced ferroptosis but negatively correlated with expression of ferritin heavy chain 1 and ferritin light chain.
    Yang FC; Wang C; Zhu J; Gai QJ; Mao M; He J; Qin Y; Yao XX; Wang YX; Lu HM; Cao MF; He MM; Wen XM; Leng P; Cai XW; Yao XH; Bian XW; Wang Y
    Lab Invest; 2022 Jul; 102(7):741-752. PubMed ID: 35351965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD147 confers temozolomide resistance of glioma cells via the regulation of β-TrCP/Nrf2 pathway.
    Bu X; Qu X; Guo K; Meng X; Yang X; Huang Q; Dou W; Feng L; Wei X; Gao J; Sun W; Chao M; Han L; Hu Y; Shen L; Zhang J; Wang L
    Int J Biol Sci; 2021; 17(12):3013-3023. PubMed ID: 34421346
    [No Abstract]   [Full Text] [Related]  

  • 5. RUNX1 (RUNX family transcription factor 1), a target of microRNA miR-128-3p, promotes temozolomide resistance in glioblastoma multiform by upregulating multidrug resistance-associated protein 1 (MRP1).
    Xu J; Song J; Xiao M; Wang C; Zhang Q; Yuan X; Tian S
    Bioengineered; 2021 Dec; 12(2):11768-11781. PubMed ID: 34895074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Sensitivity to ALDH1A3-Dependent Ferroptosis in TMZ-Resistant Glioblastoma Cells.
    Wu Y; Franzmeier S; Liesche-Starnecker F; Schlegel J
    Cells; 2023 Oct; 12(21):. PubMed ID: 37947601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-147a Targets SLC40A1 to Induce Ferroptosis in Human Glioblastoma.
    Xu P; Ge FH; Li WX; Xu Z; Wang XL; Shen JL; Xu AB; Hao RR
    Anal Cell Pathol (Amst); 2022; 2022():2843990. PubMed ID: 35942174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-Regulation of Cyclooxygenase-2 (COX-2) Expression by Temozolomide (TMZ) in Human Glioblastoma (GBM) Cell Lines.
    Lombardi F; Augello FR; Artone S; Gugu MK; Cifone MG; Cinque B; Palumbo P
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIM25 promotes temozolomide resistance in glioma by regulating oxidative stress and ferroptotic cell death via the ubiquitination of keap1.
    Wei J; Wang L; Zhang Y; Sun T; Zhang C; Hu Z; Zhou L; Liu X; Wan J; Ma L
    Oncogene; 2023 Jun; 42(26):2103-2112. PubMed ID: 37188737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
    Roh JL; Kim EH; Jang H; Shin D
    Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-1268a regulates ABCC1 expression to mediate temozolomide resistance in glioblastoma.
    Li Y; Liu Y; Ren J; Deng S; Yi G; Guo M; Shu S; Zhao L; Peng Y; Qi S
    J Neurooncol; 2018 Jul; 138(3):499-508. PubMed ID: 29876787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A targetable PRR11-DHODH axis drives ferroptosis- and temozolomide-resistance in glioblastoma.
    Miao Z; Xu L; Gu W; Ren Y; Li R; Zhang S; Chen C; Wang H; Ji J; Chen J
    Redox Biol; 2024 Jul; 73():103220. PubMed ID: 38838551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2/Keap1/xCT signaling.
    Fu D; Wang C; Yu L; Yu R
    Cell Mol Biol Lett; 2021 Jun; 26(1):26. PubMed ID: 34098867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boric acid Increases Susceptibility to Chemotherapy by Targeting the Ferritinophagy Signaling Pathway in TMZ Resistant Glioblastoma Cells.
    Hacioglu C; Tuncer C
    Biol Trace Elem Res; 2024 Aug; 202(8):3574-3587. PubMed ID: 37906374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting.
    Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y
    Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of KDM4A-mediated histone methylation on temozolomide resistance in glioma cells through the HUWE1/ROCK2 axis.
    Li XX; Xu JK; Su WJ; Wu HL; Zhao K; Zhang CM; Chen XK; Yang LX
    Kaohsiung J Med Sci; 2024 Feb; 40(2):161-174. PubMed ID: 37873881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the reverse transsulfuration pathway through NRF2/CBS confers erastin-induced ferroptosis resistance.
    Liu N; Lin X; Huang C
    Br J Cancer; 2020 Jan; 122(2):279-292. PubMed ID: 31819185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.
    Chen Z; Wei X; Shen L; Zhu H; Zheng X
    Cancer Sci; 2019 Jan; 110(1):389-400. PubMed ID: 30431207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of Nrf2 Signalling and the Inhibition of Erastin-Induced Ferroptosis by Ferulic Acid in MIN6 Cells.
    Kose T; Sharp PA; Latunde-Dada GO
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
    Shin D; Kim EH; Lee J; Roh JL
    Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.